bluebird bio, Inc. BLUE

I’m afraid of the Q4 numbers actually

I hopevAlina Habba is not lead counsel

This is all about the court mess

The market doesn’t care about science or even the business they only care about share price and this one’s going down

The support is at .80 and the selloff will test it. Thank God it’s not tax loss season because every stock has a point of absurdity

At least it was a hell of a run to the lucky ones

The days of biotech speculation like the past 30+ years appears to be over and stock gains now will be driven by earnings. The lofty multiples finally reflect reality. The only speculation left is in acquisitions and large pharma will wait till the end of a stock collapse to see if they can buy drugs out of BK

Learn from google founder let the young generation to run

Step down let the young generation a chance to run

From $90 to $1 if I were CEO how would I’m going toface my family and friends